Is postoperative adjuvant radioactive iodine ablation therapy always necessary for intermediate-risk papillary thyroid cancer patients with central neck metastasis?

K Han, HM Noh, HM Jeong, YC Lim - Annals of Surgical Oncology, 2021 - Springer
Papillary thyroid cancer (PTC) is commonly associated with neck lymph node … radioactive
iodine (RAI) ablation therapy. This study aimed to analyze the effectiveness of RAI ablation

Update on the systemic management of radioactive iodine refractory differentiated thyroid cancer

G Babu, CT Kainickal - Molecular and Clinical …, 2021 - spandidos-publications.com
… followed by remnant thyroid bed ablation using radioiodine, as … of patients who are
non‑responsive to radioactive iodine (RAIefficacy in numerous types of tumor. Targeted therapies …

No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH

MC Campopiano, D Podestà, F Bianchi… - European Journal of …, 2020 - academic.oup.com
efficacy and the outcome of our two groups of patients. … by radioiodine (131-I) initial treatment,
either for ablation or as … thyroidectomy, 131-I remnant ablation and high activities of 131-I …

[HTML][HTML] Clinical outcomes of N1b papillary thyroid cancer patients treated with two different doses of radioiodine ablation therapy

M Jin, J Ahn, YM Lee, TY Sung… - Endocrinology and …, 2020 - synapse.koreamed.org
effectiveness and adverse effects, we need more accurate evidence for the efficacy of higher
doses of RAI as … mCi of RAI for N1b PTC patients is sufficient for remnant ablation. However, …

Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade

FA Verburg, G Flux, L Giovanella… - European journal of …, 2020 - Springer
… Search terms used included “differentiated thyroid cancer” and “radioiodine therapy” …
evidence supporting the effectiveness of RIT in these patients. Yang et al. [8] studied 11,832 DTC …

Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up

V Ahtiainen, L Vaalavirta, M Tenhunen… - Acta …, 2020 - Taylor & Francis
… lower activities representing equal effectiveness in ablation of the thyroid remnant into light.
Previous … To eradicate and control papillary or follicular thyroid cancer remnant, radioiodine

[PDF][PDF] Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in intermediate-risk papillary thyroid carcinoma patients with low postoperative …

P Chen, JX Luo, W Ouyang, HJ Feng, JQ Wu, J Wang… - 2021 - pdfs.semanticscholar.org
… and commentary examining the effectiveness of radioactive iodine remnant ablation in well…
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review …

[PDF][PDF] Efficacy of 131I therapy and its influencing factors in children and adolescents with differentiated thyroid carcinoma

M Luo, Y Hu - J BUON, 2021 - jbuon.com
ablation of thyroid remnants was efficacious in 61 (64.9%) patients, but not in 33 (35.1%)
patients … RAIU represents the ability of thyroid tissues and metastases to specifically take in RAI, …

[HTML][HTML] Differentiated thyroid carcinoma: an update

P van Houten, RT Netea-Maier, JW Smit - Best Practice & Research …, 2023 - Elsevier
… stronger evidence for matters such as the indications and application of RAI-remnant ablation
in patients with low-risk DTC, and efficacy of TKIs in advanced DTC. In addition, there is …

Recurrent differentiated thyroid cancer: the current treatment options

A Coca-Pelaz, JP Rodrigo, JP Shah, IJ Nixon, DM Hartl… - Cancers, 2023 - mdpi.com
… , RAI is a treatment option that should be considered. Postoperative RAI remnant ablation for
DTC is also intended to ablate … not superior in efficacy to dabrafenib alone for such patients. …